Associazione Nazionale Medici Cardiologi Ospedalieri

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
Dapagliflozin reduces systemic PCSK9 levels in preclinical models of short-term doxorubicin cardiotoxicity through NLRP3 inflammasome/IL-1β: a first evidence of SGLT-2/PCSK9 cross-talk in cardioncology
Anno:
2023
Background: Anthracyclines are an effective and widely used chemotherapy agent in the treatment of multiple solid organ tumors and hematologic malignancies. The use of anthracyclines as a standard cancer therapy is limited by the potential for the development of cardiac dysfunction, arrhythmias, and clinical heart failure. In recent five…
TEAMWORK IS SUCCESSFUL (2): PATIENT WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) AND MULTIPLE HEART MASSES
Anno:
2023
Introduction Patients (Pts) with lymphoma are at high risk of cardiovascular events for the cardiotoxic effects of therapies and direct involvement of the heart. Autopsy series, indeed, indicate that cardiac localization may be observed in 10 – 25% of DLBCL Pts. The presence of cardiac mass, in DLBCL poses…
TEAMWORK IS SUCCESSFULL (4): PROGRESSION OF CORONARY ATHEROSCLEROSIS IN A PERIPHERAL T-CELL LYMPHOMA AND PAPILLARY RENAL CELL CARCINOMA SURVIVOR
Anno:
2023
Introduction Growing evidence highlight cancer and cardiovascular diseases (CVD) share common risk factors, including genetic ones, and underlying pathogenesis. Such paradigm has significant implications for cancer survivors, an exponential growing cohort of patients (Pts), due to notable improvements in survival achieved with new oncological treatments. However, many new agents…
ORAL ANTICOAGULATION THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION AND CANCER: A LITERATURE REVIEW
Anno:
2023
INTRODUCTION Cancer and atrial fibrillation (AF) are two very frequent conditions that share common pathophysiological and epidemiological features. Spontaneous coagulation is associated with malignant neoplasia as well as prothrombotic potential due to the overexpression of procoagulants. Balancing the increased and competing risks of clotting and bleeding in these patients…
A BIG MASS AROUND THE HEART: SHOULD I BE WORRIED?
Anno:
2023
Lipomas account for about 10% of all cardiac tumors and symptoms are often secondary to the compression of cardiac chambers and the consequent hemodynamic impact. We report the case of a 76-year-old woman with no cardiological history, undergoing oncological follow-up for breast cancer underwent a left radical mastectomy in…
HEART FAILURE DURING ACUTE CORONARY SYNDROME AND THE LONG-TERM RISK OF INCIDENT CANCER. THE ABC-9* STUDY ON HEART DISEASE.
Anno:
2023
Introduction: Recent reports have suggested a higher risk of incident cancer among patients with pre-existing Heart failure (HF) in community-based cohorts. Methods: To investigate the association between heart failure (HF) during hospitalization with acute coronary syndrome (ACS) and the very long-term cancer risk, we enrolled 572 patients admitted with…